PC
GWPH

Polar Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Polar Capital’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-155,658
Closed -$26.8M – 313
2019
Q2 		$26.8M Hold
155,658
– – 0.24% 134
2019
Q1 		$26.2M Buy
155,658
+105,658
+211% +$15.7M 0.24% 134
2018
Q4 		$4.87M Buy
+50,000
New +$6.56M 0.05% 212

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Polar Capital's GWPH Position: Q3 2019 in Review

Polar Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 155,658 shares — an estimated $26.8M sold.

Polar Capital first reported a position in GWPH in Q4 2018 and held it in 3 quarters. The position peaked at $26.8M in Q2 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

  • Polar Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Polar Capital sold 155,658 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $26.8M.
  • Polar Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 3 quarters.
  • Polar Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $26.8M in Q2 2019.
  • 316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Polar Capital's 13F filing for Q3 2019, filed 14 Nov 2019.